Complexity and Misrepresentation in the New York Times

Robert Harington comments on a New York Times article by Kate Murphy , published on Sunday 13th March, 2016, suggesting that when journalists write such an article they, do not fan the flames of fundamentalism, recognize the complexity at hand, and understand that there is a constructive debate to be had.

Why Is ClinicalTrials.gov Still Struggling?

With no clear benefits to researchers, a frustrating user experience, and no penalties for non-compliance, ClinicalTrials.gov is becoming increasingly irrelevant to clinical researchers and the world at large with each passing day. What does this mean for public access to research results? Is an obligation to patients putting themselves at risk in trials being breached? Why has it failed to live up to its potential?

We’re not Drop-outs, We’re Quitters. There’s a Difference!

It was a little while back now that a controversial blogger attacked one or more of the authors of the Scholarly Kitchen for being former academics, questioning whether such people should be working in publishing. In today’s post, Phill Jones argues that such rhetoric contributes to a stigma that is damaging to the health of academia.

Sci-Hub and the Four Horsemen of the Internet

Sci-Hub sets a reprehensible example, but publishers cannot be content simply to stamp out such services. In order to evolve the industry into the future, publishers have to provide services that make Sci-Hub and its ilk seem old-fashioned and inconvenient to use.

The Illicit Love Affair between Open Access and Traditional Publishing

At the recent PSP conference there was a panel on the cost of complying with the many new open access mandates from funding bodies. The panel explored the cost of compliance and how to reduce those costs. The current regulatory regime is complicated and administratively expensive, but the mandates will continue to be promulgated because the people calling for them are not the ones that have to implement them.